AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 61 filers reported holding AMICUS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,687,000 | +58.2% | 178,212 | +5.6% | 0.01% | +57.1% |
| Q2 2017 | $1,699,000 | +80.6% | 168,709 | +27.9% | 0.01% | +75.0% |
| Q1 2017 | $941,000 | +60.0% | 131,945 | +11.5% | 0.00% | +100.0% |
| Q4 2016 | $588,000 | -34.2% | 118,382 | -1.9% | 0.00% | -50.0% |
| Q3 2016 | $893,000 | +45.7% | 120,717 | +7.5% | 0.00% | +33.3% |
| Q2 2016 | $613,000 | -31.3% | 112,325 | +8.5% | 0.00% | -25.0% |
| Q1 2016 | $892,000 | -12.9% | 103,569 | -1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,024,000 | -29.5% | 105,597 | +1.7% | 0.00% | -42.9% |
| Q3 2015 | $1,453,000 | +12.1% | 103,843 | +13.4% | 0.01% | +40.0% |
| Q2 2015 | $1,296,000 | +2441.2% | 91,590 | +274.4% | 0.01% | – |
| Q1 2014 | $51,000 | -10.5% | 24,464 | 0.0% | 0.00% | – |
| Q4 2013 | $57,000 | 0.0% | 24,464 | 0.0% | 0.00% | – |
| Q3 2013 | $57,000 | +1.8% | 24,464 | +2.5% | 0.00% | – |
| Q2 2013 | $56,000 | – | 23,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |